DECN Recap & More

Decision Diagnostics, Corp. DECN 

We began tracking DECN just under three weeks ago, back on the morning of March 19th. The stock caught our attention after announcing that it was working on a rapid-result COVID-19 test. Subsequent to that point in time, it was trading for as little as .056/share.

Yesterday, following another tag in our extended watchlist, and as an update on the company’s coronavirus test was provided (excerpt and link below), the stock reached some very impressive new highs. It’s not the first coronavirus related play we’ve scored on, and it won’t be the last.

DECN ran 216% intraday from .125 to a new high of .395. From our initially observed low from the week before last, the stock has now exhibited an upswing of 605%

Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc.  …announces today that the company has received the Pre-EUA Acknowledgement letter from the U.S. FDA for device (serial number) PEUA200232, GenViro Covid-19 Screening Kit. This grant by the FDA is a major milestone in our GenViro!™ Covid-19 test kit development (>>View Full PR)


Johnson & Johnson JNJ – Recap

After seeing success with a number of different targets within the JNJ chain over the past week and change, we rolled our potential strike prices up to the JNJ Weekly $140-142 Calls yesterday morning.

Being one of the lead candidates for potentially developing an effective COVID-19 vaccine, it puts JNJ in a somewhat unique position, as experts have repeatedly stated that the world cannot begin to fully recover until a viable vaccine is being widely administered sometime next year.

Our move to the $140-142 Calls proved prudent yesterday, as early activity provided the following intraday opportunities: 

JNJ Weekly $140-142 Calls
$140: .89-2.88 (+224%)
$141: .62-2.31 (+273%)
$142: .43-1.67 (+288%)
_____

Fresh Ideas:
LEVI 04/17 $12-13 Calls
SGH 04/17 $22.50-25 Calls 


Extended  Watchlist:
BIEI, MBRX PINS, BNGO, SONN, EFC, NYMT

Blue Horseshoe Stocks: TEUM Recap & More

Pareteum Corp. TEUM
Just yesterday, we were commenting on the large number of stocks we’ve recently tracked for large gains despite already trading at more than a dollar per share. We’ve been seeing OTC-type gains from NYSE and NASDAQ plays, and TEUM is another good example of this.

The day after our mention of TEUM in our morning report from February 8th, we observed a low of 1.72 in TEUM, and it hasn’t looked back since. Yesterday, the stock reached a new high of 3.59, representing a six-week double-bag swing of 108%


Geron Corp. GERN

GERN, another of our calls to make a solid six week run, added another new high yesterday, just after our morning report in which we outlined its prior performance. The stock had already showed us a move from 2.025-5.00 (+147%).

Yesterday’s trading range took it from a low of 5.08 to a new high of 6.68. That works out to an intraday pop of 31% and increases our total observed range to an impressive 230%



Nike Inc. NKE – Fresh Options Idea

Nike posted a beat on earning sales and revs yesterday post-market, and is up in early trading today, so we’re definitely going to want to put a range of calls on watch as we close out another trading week.

We’ll be tracking the NKE Weekly $66.50-68 Calls, but remember, NEVER attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds.

______

Added Idea:
At Home Group, Inc. HOME 04/20 $30 Calls

 


Extended Watchlist:
ITRK, ABBV, CLVS, SGH, GSK